Stendra - (50,100,200 mg; Tablet, Oral)

Generic Name	Avanafil	Innovator	Metuchen Pharma
Dosage	50,100,200 mg; Tablet, Oral	Branded US Sales	Less Than $1000 mn
Probable FTF	Less Than 5	Known Para IV Filers	Less Than 5
Other ANDA developers	Less Than 5	Tentative Approvals	None
Final Approvals	None	Generic Launches	None
Indication	Indicated for the treatment of erectile dysfunction.
Complexities	Yes

Executive Summary

Patent Status

Launch Timelines and Competition

Company	FTF Status / 180 days exclusivity	30-Months stay	Current Litigation Status	Current Approval Status	Likelihood of launch
******	*** \ **	*** **, ****	*******	****	******* *** **** (***** ******) *** *** ****
******* *****	** \ **	*** *, ****	*******	****	******* *** **** (***** ******) *** *** ****

Chronology Of Events